The World Health Organization (WHO) is in international entity that works with governments and other partners to ensure the highest attainable level of health for all people. Several treatment guidelines about substance use have been published by WHO. The topics include community management of opioid overdose, identification and management of substance use and SUDs in […]
IRETA worked with ASAM to develop the Appropriate Use of Drug Testing in Clinical Addiction Medicine document to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction. A Journal of Addiction Medicine article summarizes the guidelines, and a full consensus […]
These clinical guidelines were prepared for the City of Philadelphia Department of Behavioral Health and Intellectual disability Services by IRETA with support from Community Care Behavioral Health. The project was conceived in response to frequent benzodiazepine use among individuals in medication-assisted treatment and a relative absence of research-based guidance on clinically effective treatment strategies for […]
A guideline is intended to improve patient outcomes and local management of patients with substance use disorder. The VA/DoD Clinical Practice Guidelines for Management of Substance Use Disorder describes the critical decision points in the management of Substance Use Disorder. It provides clear and comprehensive evidence-based recommendations incorporating current information and practices for practitioners throughout the […]
The Substance Abuse and Mental Health Administration (SAMHSA) publishes a series of best-practice manuals for the treatment of substance use disorders and other related topics. The 60+ Treatment Improvement Protocols (TIPS) are available for download online, or can be ordered in print.
ASAM’s National Practice Guideline provides information on evidence-based treatment of opioid use disorder, and is the first to address all of the FDA-approved medications available to treat addiction involving opioid use and opioid overdose in a single document. Access the Guideline here